Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Sudden myelopathy secondary to therapeutic total-body hyperthermia after spinal-cord irradiation

Journal Article · · New Engl. J. Med.; (United States)
Hyperthermia is a new method of treatment receiving increasing clinical attention in cancer therapy. Its efficacy has been well demonstrated in animals, but its indications, contraindications, and appropriate place in cancer therapy have yet to be defined. We report three cases of acute myelopathy in patients undergoing hyperthermia after spinal-cord irradiation within the preceding two months. Post-mortem examination in one case revealed findings similar to those seen in myelopathy resulting from long-term irradiation. Several neurologic side effects have been reported previously with total-body hyperthermia - most commonly peripheral neuropathy, but not myelopathy. The mechanism of action of hyperthermia in cancer therapy (with or without prior irradiation) is unknown. The experience reported suggests that in some patients hyperthermia may potentiate radiation-induced damage to the spinal cord or otherwise interact to cause acute spinal-cord necrosis.
Research Organization:
Univ. of Mississippi, Jackson
OSTI ID:
6565609
Journal Information:
New Engl. J. Med.; (United States), Journal Name: New Engl. J. Med.; (United States) Vol. 304:10; ISSN NEJMA
Country of Publication:
United States
Language:
English